Chronic  ||| S:0 E:8 ||| JJ
migraine ||| S:8 E:16 ||| NN
:  ||| S:16 E:18 ||| :
its  ||| S:18 E:22 ||| PRP$
epidemiology  ||| S:22 E:35 ||| NN
and  ||| S:35 E:39 ||| CC
impact  ||| S:39 E:46 ||| NN
Chronic  ||| S:46 E:54 ||| FW
migraine  ||| S:54 E:63 ||| FW
( ||| S:63 E:64 ||| -LRB-
that  ||| S:64 E:69 ||| WDT
is  ||| S:69 E:72 ||| VBZ
to  ||| S:72 E:75 ||| TO
say ||| S:75 E:78 ||| VB
,  ||| S:78 E:80 ||| ,
cases  ||| S:80 E:86 ||| NNS
where  ||| S:86 E:92 ||| WRB
migraine  ||| S:92 E:101 ||| NN
is  ||| S:101 E:104 ||| VBZ
suffered  ||| S:104 E:113 ||| VBN
on  ||| S:113 E:116 ||| IN
15  ||| S:116 E:119 ||| CD
or  ||| S:119 E:122 ||| CC
more  ||| S:122 E:127 ||| JJR
days  ||| S:127 E:132 ||| NNS
per  ||| S:132 E:136 ||| IN
month ||| S:136 E:141 ||| NN
)  ||| S:141 E:143 ||| -RRB-
is  ||| S:143 E:146 ||| VBZ
an  ||| S:146 E:149 ||| DT
illness  ||| S:149 E:157 ||| NN
that  ||| S:157 E:162 ||| WDT
affects  ||| S:162 E:170 ||| VBZ
approximately  ||| S:170 E:184 ||| RB
0.5-2.5 ||| S:184 E:191 ||| CD
%  ||| S:191 E:193 ||| NN
of  ||| S:193 E:196 ||| IN
the  ||| S:196 E:200 ||| DT
population ||| S:200 E:210 ||| NN
,  ||| S:210 E:212 ||| ,
depending  ||| S:212 E:222 ||| VBG
on  ||| S:222 E:225 ||| IN
the  ||| S:225 E:229 ||| DT
statistics  ||| S:229 E:240 ||| NNS
that  ||| S:240 E:245 ||| WDT
are  ||| S:245 E:249 ||| VBP
analysed  ||| S:249 E:258 ||| VBN
and  ||| S:258 E:262 ||| CC
the  ||| S:262 E:266 ||| DT
definition  ||| S:266 E:277 ||| NN
of  ||| S:277 E:280 ||| IN
chronic  ||| S:280 E:288 ||| JJ
migraine  ||| S:288 E:297 ||| NNS
used ||| S:297 E:301 ||| VBN
.  ||| S:301 E:303 ||| .
The  ||| S:303 E:307 ||| DT
incidence  ||| S:307 E:317 ||| NN
of  ||| S:317 E:320 ||| IN
transformation  ||| S:320 E:335 ||| NN
from  ||| S:335 E:340 ||| IN
episodic  ||| S:340 E:349 ||| JJ
to  ||| S:349 E:352 ||| TO
chronic  ||| S:352 E:360 ||| JJ
migraine  ||| S:360 E:369 ||| NN
is  ||| S:369 E:372 ||| VBZ
3 ||| S:372 E:373 ||| CD
%  ||| S:373 E:375 ||| NN
per  ||| S:375 E:379 ||| IN
year ||| S:379 E:383 ||| NN
,  ||| S:383 E:385 ||| ,
and  ||| S:385 E:389 ||| CC
6 ||| S:389 E:390 ||| CD
%  ||| S:390 E:392 ||| NN
go  ||| S:392 E:395 ||| VB
from  ||| S:395 E:400 ||| IN
low-frequency  ||| S:400 E:414 ||| NNP
( ||| S:414 E:415 ||| -LRB-
1-9  ||| S:415 E:419 ||| CD
days ||| S:419 E:423 ||| NNS
/ ||| S:423 E:424 ||| JJ
month ||| S:424 E:429 ||| NN
)  ||| S:429 E:431 ||| -RRB-
to  ||| S:431 E:434 ||| TO
high-frequency  ||| S:434 E:449 ||| JJ
migraine  ||| S:449 E:458 ||| NNS
( ||| S:458 E:459 ||| -LRB-
10-14  ||| S:459 E:465 ||| CD
days ||| S:465 E:469 ||| NNS
/ ||| S:469 E:470 ||| JJ
month ||| S:470 E:475 ||| NN
) ||| S:475 E:476 ||| -RRB-
.  ||| S:476 E:478 ||| .
The  ||| S:478 E:482 ||| DT
risk  ||| S:482 E:487 ||| NN
factors  ||| S:487 E:495 ||| NNS
for  ||| S:495 E:499 ||| IN
developing  ||| S:499 E:510 ||| VBG
chronic  ||| S:510 E:518 ||| JJ
migraine  ||| S:518 E:527 ||| NNS
are  ||| S:527 E:531 ||| VBP
genetic ||| S:531 E:538 ||| JJ
,  ||| S:538 E:540 ||| ,
frequent  ||| S:540 E:549 ||| JJ
use  ||| S:549 E:553 ||| NN
of  ||| S:553 E:556 ||| IN
painkillers ||| S:556 E:567 ||| NN
,  ||| S:567 E:569 ||| ,
being  ||| S:569 E:575 ||| VBG
female ||| S:575 E:581 ||| NN
,  ||| S:581 E:583 ||| ,
having  ||| S:583 E:590 ||| VBG
poor  ||| S:590 E:595 ||| JJ
hygienic-dietary  ||| S:595 E:612 ||| JJ
habits ||| S:612 E:618 ||| NNS
,  ||| S:618 E:620 ||| ,
developing  ||| S:620 E:631 ||| VBG
anxiety ||| S:631 E:638 ||| NN
/ ||| S:638 E:639 ||| CD
depression ||| S:639 E:649 ||| NN
,  ||| S:649 E:651 ||| ,
having  ||| S:651 E:658 ||| VBG
a  ||| S:658 E:660 ||| DT
low  ||| S:660 E:664 ||| JJ
socioeconomic  ||| S:664 E:678 ||| JJ
status ||| S:678 E:684 ||| NN
,  ||| S:684 E:686 ||| ,
suffering  ||| S:686 E:696 ||| VBG
from  ||| S:696 E:701 ||| IN
obesity  ||| S:701 E:709 ||| NN
and  ||| S:709 E:713 ||| CC
being  ||| S:713 E:719 ||| VBG
divorced  ||| S:719 E:728 ||| VBN
or  ||| S:728 E:731 ||| CC
widowed ||| S:731 E:738 ||| NN
.  ||| S:738 E:740 ||| .
Despite  ||| S:740 E:748 ||| IN
the  ||| S:748 E:752 ||| DT
modification  ||| S:752 E:765 ||| NN
of  ||| S:765 E:768 ||| IN
the  ||| S:768 E:772 ||| DT
risk  ||| S:772 E:777 ||| NN
factors ||| S:777 E:784 ||| NNS
,  ||| S:784 E:786 ||| ,
it  ||| S:786 E:789 ||| PRP
has  ||| S:789 E:793 ||| VBZ
still  ||| S:793 E:799 ||| RB
not  ||| S:799 E:803 ||| RB
been  ||| S:803 E:808 ||| VBN
proved  ||| S:808 E:815 ||| VBN
that  ||| S:815 E:820 ||| IN
the  ||| S:820 E:824 ||| DT
chances  ||| S:824 E:832 ||| NNS
of  ||| S:832 E:835 ||| IN
developing  ||| S:835 E:846 ||| VBG
chronic  ||| S:846 E:854 ||| JJ
migraine  ||| S:854 E:863 ||| NN
can  ||| S:863 E:867 ||| MD
be  ||| S:867 E:870 ||| VB
lowered ||| S:870 E:877 ||| VBN
.  ||| S:877 E:879 ||| .
Chronic  ||| S:879 E:887 ||| JJ
migraine  ||| S:887 E:896 ||| NN
has  ||| S:896 E:900 ||| VBZ
an  ||| S:900 E:903 ||| DT
important  ||| S:903 E:913 ||| JJ
impact  ||| S:913 E:920 ||| NN
on  ||| S:920 E:923 ||| IN
patients ||| S:923 E:931 ||| NNS
'  ||| S:931 E:933 ||| POS
quality  ||| S:933 E:941 ||| NN
of  ||| S:941 E:944 ||| IN
life ||| S:944 E:948 ||| NN
,  ||| S:948 E:950 ||| ,
as  ||| S:950 E:953 ||| RB
measured  ||| S:953 E:962 ||| VBN
on  ||| S:962 E:965 ||| IN
disability ||| S:965 E:975 ||| NN
,  ||| S:975 E:977 ||| ,
quality  ||| S:977 E:985 ||| NN
of  ||| S:985 E:988 ||| IN
life  ||| S:988 E:993 ||| NN
and  ||| S:993 E:997 ||| CC
impact  ||| S:997 E:1004 ||| NN
on  ||| S:1004 E:1007 ||| IN
daily  ||| S:1007 E:1013 ||| JJ
activities  ||| S:1013 E:1024 ||| NNS
scales ||| S:1024 E:1030 ||| NNS
.  ||| S:1030 E:1032 ||| .
These  ||| S:1032 E:1038 ||| DT
patients  ||| S:1038 E:1047 ||| NNS
have  ||| S:1047 E:1052 ||| VBP
twice  ||| S:1052 E:1058 ||| RB
the  ||| S:1058 E:1062 ||| DT
chance  ||| S:1062 E:1069 ||| NN
of  ||| S:1069 E:1072 ||| IN
suffering  ||| S:1072 E:1082 ||| VBG
from  ||| S:1082 E:1087 ||| IN
depression ||| S:1087 E:1097 ||| NN
,  ||| S:1097 E:1099 ||| ,
anxiety  ||| S:1099 E:1107 ||| NN
and  ||| S:1107 E:1111 ||| CC
chronic  ||| S:1111 E:1119 ||| JJ
pain ||| S:1119 E:1123 ||| NN
,  ||| S:1123 E:1125 ||| ,
which  ||| S:1125 E:1131 ||| WDT
means  ||| S:1131 E:1137 ||| VBZ
they  ||| S:1137 E:1142 ||| PRP
therefore  ||| S:1142 E:1152 ||| RB
need  ||| S:1152 E:1157 ||| VB
greater  ||| S:1157 E:1165 ||| JJR
health  ||| S:1165 E:1172 ||| NN
care ||| S:1172 E:1176 ||| NN
.  ||| S:1176 E:1178 ||| .
Many  ||| S:1178 E:1183 ||| JJ
have  ||| S:1183 E:1188 ||| VBP
still  ||| S:1188 E:1194 ||| RB
to  ||| S:1194 E:1197 ||| TO
be  ||| S:1197 E:1200 ||| VB
diagnosed  ||| S:1200 E:1210 ||| VBN
and  ||| S:1210 E:1214 ||| CC
treated ||| S:1214 E:1221 ||| VBN
,  ||| S:1221 E:1223 ||| ,
however ||| S:1223 E:1230 ||| RB
.  ||| S:1230 E:1232 ||| .
In  ||| S:1232 E:1235 ||| IN
a  ||| S:1235 E:1237 ||| DT
Spanish  ||| S:1237 E:1245 ||| JJ
epidemiological  ||| S:1245 E:1261 ||| JJ
study ||| S:1261 E:1266 ||| NN
,  ||| S:1266 E:1268 ||| ,
a  ||| S:1268 E:1270 ||| DT
follow-up  ||| S:1270 E:1280 ||| NN
was  ||| S:1280 E:1284 ||| VBD
carried  ||| S:1284 E:1292 ||| VBN
out  ||| S:1292 E:1296 ||| RP
on  ||| S:1296 E:1299 ||| IN
patients  ||| S:1299 E:1308 ||| NNS
with  ||| S:1308 E:1313 ||| IN
chronic  ||| S:1313 E:1321 ||| JJ
daily  ||| S:1321 E:1327 ||| JJ
headache  ||| S:1327 E:1336 ||| NN
after  ||| S:1336 E:1342 ||| IN
undergoing  ||| S:1342 E:1353 ||| VBG
a  ||| S:1353 E:1355 ||| DT
therapeutic  ||| S:1355 E:1367 ||| JJ
intervention  ||| S:1367 E:1380 ||| NN
and  ||| S:1380 E:1384 ||| CC
up  ||| S:1384 E:1387 ||| RB
to  ||| S:1387 E:1390 ||| TO
60 ||| S:1390 E:1392 ||| CD
%  ||| S:1392 E:1394 ||| NN
of  ||| S:1394 E:1397 ||| IN
the  ||| S:1397 E:1401 ||| DT
patients  ||| S:1401 E:1410 ||| NNS
showed  ||| S:1410 E:1417 ||| VBD
improvement ||| S:1417 E:1428 ||| NN
.  ||| S:1428 E:1430 ||| .
In  ||| S:1430 E:1433 ||| IN
other  ||| S:1433 E:1439 ||| JJ
words ||| S:1439 E:1444 ||| NNS
,  ||| S:1444 E:1446 ||| ,
with  ||| S:1446 E:1451 ||| IN
increased  ||| S:1451 E:1461 ||| JJ
interest  ||| S:1461 E:1470 ||| NN
and  ||| S:1470 E:1474 ||| CC
diagnosis  ||| S:1474 E:1484 ||| NN
of  ||| S:1484 E:1487 ||| IN
this  ||| S:1487 E:1492 ||| DT
illness ||| S:1492 E:1499 ||| NN
,  ||| S:1499 E:1501 ||| ,
many  ||| S:1501 E:1506 ||| JJ
patients  ||| S:1506 E:1515 ||| NNS
would  ||| S:1515 E:1521 ||| MD
benefit  ||| S:1521 E:1529 ||| VB
from  ||| S:1529 E:1534 ||| IN
suitable  ||| S:1534 E:1543 ||| JJ
treatments ||| S:1543 E:1553 ||| NNS
.  ||| S:1553 E:1555 ||| .
